Chi­na's mar­ket reg­u­la­tor fines, con­fis­cates rev­enue from phar­mas for mo­nop­o­liz­ing APIs for ep­i­neph­rine

Chi­na’s mar­ket reg­u­la­tor, the State Ad­min­is­tra­tion for Mar­ket Reg­u­la­tion, an­nounced on Sun­day that it fined and con­fis­cat­ed rev­enue from two phar­ma com­pa­nies for what it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER